NEWSMAKERS Promotions and appointments of area executives
DANIELA FREEMAN,
Petroleum Industry Data Exchange, has joined the organization as standards and compliance manager.
J. STEPHEN BARRICK,
a Hicks Thomas appellate specialist and business trial lawyer, has been promoted to partner.
SUSAN JISTEL SPILLIOS,
Axia Partners, has joined the consulting firm as a partner focused on business development.
DR. DANIEL J. PENNY,
Texas Children’s Hospital chief of pediatric cardiology, has been named the American Heart Association’s 2018 Helen B. Taussig Memorial Lecturer.
GILBERTO ORDONEZ,
of Wood, has been named senior vice president of brownfield solutions in the firm’s Asset Solutions Americas business.
JENNY MEYER,
Pilko & Associates, has been promoted to senior vice president, business development, at the advisory firm.
GAIL BRANCH,
MIAT College of Technology, has joined the Houston campus as the director of career and student services.
OMAR BOULOS,
Accenture, has been named North America growth and strategy lead, resources operating group.
CHELSEA SCOTT,
KDW, has been named as marketing director for the Houston-based design/build construction firm.
LUDOVIC POIRIER,
Hotel Alessandra, has been promoted to director of food and beverage for the property.
KAREN DIAZ,
Petroleum Industry Data Exchange, has joined the organization as marketing and events manager.
GILBERT A. HERRERA,
LaPorte CPAs & Business Advisors, has joined the firm as a director in the consulting services group.
JOHN LYLE,
Pearland Economic Development Corp., has been appointed to the organization’s board of directors.
GONZAGUE SALLO,
Hotel Alessandra, has been named assistant director of outlets overseeing Lucienne restaurant and Bardot Lounge.
JAMES BEMENT,
Hydraulic Systems, has been appointed as the drilling rig equipment provider’s chief executive officer.
JOHN NOLAN,
NAI Partners, has joined the commercial real estate firm’s investment fund as vice president of asset management.
ADAM R. FRACHT,
Stibbs & Co., has been promoted to partner at the Houston-area business law firm.
ANTHONY H. KIM,
Marker Therapeutics, has been appointed chief financial officer of the clinical-stage immuno-oncology company.